Health and Medicine

Every year the ESPGHAN Annual Meeting attracts healthcare professionals, scientists, patients, parents and industry partners in the field of Paediatric Gastroenterology, Hepatology and Nutrition, from Europe and all around the world - making the congress the largest conference of its kind worldwide. All lecturers and chairs will join us onsite to ensure the highest quality of presentations and interactions. The scientific programme will include a wide range of sessions and symposia, clinical tracks, postgraduate courses, rapid-fire sessions as well as the popular hands-on learning zones. Participants will have the opportunity to exchange ideas and expertise in an international framework, meet…

We will then discuss a broad range of disease states for which echocardiography is useful, including ischemic heart disease, valvular heart disease, pericardial disease, and cardiomyopathies. The presentations will include basic concepts as well as advanced techniques including 3-D imaging and strain imaging. Throughout the course many cases will be presented. Unique Features: - Faculty members are clinical sonographers and echocardiologists - Easy access to faculty members during the entire conference - Afternoon on pediatric/adult congenital echocardiography - Presentations involving multimodality imaging Prices: MD, PhD, DO, PharmD: USD 780.00, Residents, Sonographers, RN/NP/PA: USD 650.00 Time: 07:00 to 17:00

This conference has become a reference in the field of dementia. On May 2024, the BcnPit will emerge again as a valuable forum where professionals from all over the globe can connect and share their work and prospects about dementia. This high-quality conference will bring together panellists of recognized international scientific prestige and create and interactive space with the ultimate objective of helping people affected and their families.

Welcome to the Inaugural GLP-1-Based Therapeutics Summit! - Elucidate Strategies for Product Specialization and Indication Expansion through Pharmacoeconomic Analysis Grab your copy of the Full Agenda: https://ter.li/jphri4 Amidst the resounding success of Novo's SELECT trial, the clinical trial landscape finds itself inundated with a surge of innovative GLP-1 treatments. Each passing week witnesses the unveiling of new multi-million-dollar investments, propelling GLP-1 players to the forefront of pharmaceutical revenue growth. Uniting the industry decision-makers behind the explosion of GLP-1 assets, the GLP-1-Based Therapeutics Summit stands as a pivotal platform. Uniquely positioned, it serves as the nexus for industry decision-makers, providing invaluable…

The event will feature the latest research, delving into how these groundbreaking therapies facilitate trauma healing, promote neuroplasticity, and foster personal growth for individuals dealing with addiction. Bringing together scientists, clinicians, medical experts, policy advocates, and individuals with firsthand experience overcoming addiction through these treatments. Time: 7:45 AM - 6:00 PM

Lectures and cases will cover evidence-based practice techniques and protocols for improved diagnostic accuracy in multiple applications. At the conclusion of this activity, participants should be able to: *Apply quality improvement strategies with a focus on increasing efficiency, communication, and collaboration *Outline the fundamentals of the latest advanced techniques in MRI, CT and ultrasound, including their current roles and limitations in clinical practice *Integrate information presented in this course into efforts to improve the imaging skills of the participants *Assess the current status and future applications of advanced breast imaging technologies URLs: Tickets: https://go.evvnt.com/1778998-2?pid=154 Virtual: https://go.evvnt.com/1778998-3?pid=154 Time: 07:00 - 17:45…

Mayo Clinic's 26th Edition "Teach the Teachers" Advanced Elbow Surgical Skills Course Forge the Future: Stiff Elbow is an advanced level course designed for orthopedic surgeons with a special interest in upper extremity trauma, elbow surgery and trauma surgery. The course provides technical skills orientation, with the didactic portions limited to the necessary introductions and theoretical knowledge required for the technical components. Live surgical broadcasts used during lecture sessions demonstrate surgical techniques pertaining to this year's topic of stiff elbow as well as other areas of elbow orthopedics. Helping us to 'Forge the Future' will be our special guest and…

With the history and experience of 13 International Congresses behind us, we are now excited to announce the 14th International Congress on Autoimmunity in Ljubljana, Slovenia on 17 - 20 May 2024. Those following the course of the Autoimmunity Congresses know that in 2022, the 13th Congress was held in Athens, Greece. We made a return to our regular in-person format after the COVID-19 pandemic. We are thrilled to be back in Ljubljana after so many years for the upcoming congress! Ljubljana is a beautiful city with a rich history and cultural heritage. This stunning location will yet again provide…

Accepted papers of ICMHI 2024 will be published in International Conference Proceedings Series by ACM (ISBN: 979-8-4007-1687-4), which will be sent to Ei Compendex and Scopus for indexing, and submitted to be reviewed by Thomson Reuters Conference Proceedings Citation Index (ISI Web of Science). Submission Methods: [email protected]

Join us for Great Debates and Updates in Gastrointestinal Malignancies, a dynamic conference dedicated to exploring the latest advancements in the treatment of GI tract cancers. Over the course of multiple days, our debate-driven format presents both sides of current and controversial topics, enabling attendees to gain a comprehensive understanding through in-depth research and analysis. Whether attending in person or virtually, participants will have ample opportunities to connect with leading experts and industry leaders and foster valuable networking experiences. Furthermore, audience engagement is encouraged, allowing practitioners to reflect on how these developments directly improve their own practices. Don't miss this…

INC2024 will features state-of-the-art advances in Neonatal care and research delivered through an expert panel of local and international faculty with decades of experience at leading institutes. The event will provide attendees with an opportunity to learn, debate, and network with peers in this very active scientific field. We cordially invite neonatologists, pediatricians, researchers, nurses and other health care professionals who are interested in sharing their knowledge and research in the arena of Neonatal-Prenatal Medicine to join our leading faculty. The scientific program aims to discuss key issues and latest advances and controversies in neonatology. Prominent national and international speakers…

Despite notable advances in management, atherosclerotic cardiovascular disease (ASCVD) and its major clinical manifestations remains a leading cause of both morbidity and mortality worldwide. In the United States alone, ASCVD is the leading cause of death in most racial and ethnic populations and is estimated to cost more than $200 billion per year due to medications, healthcare service utilization, and productivity losses. Many of these human and economic costs are largely attributable to poor implementation of prevention strategies in adults and failure to control ASCVD risk factors using available medications and lifestyle interventions. The Scripps Cardiovascular Atherosclerosis conference is designed…

The main goal of this interdisciplinary, international conference is to bring together scientists and scholars who hold a range of views on the potential and possible limitations of chemical and biological processes in the origin of life and in evolution, and to explore and discuss new experimental strategies to enhance our understanding of such mechanisms and pathways. The conference will include presentations from a broad spectrum of disciplines including chemistry, biochemistry, biology, origin of life, evolution, mathematics, and philosophy. Open-floor discussion will be geared towards delineating mechanistic details, with a view to discussing and debating in such a way that…

On behalf of the Local Organising and the International Scientific Committees, it gives us great pleasure to invite you to the 42nd Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID), scheduled to take place May 20-24, 2024. While we were looking forward to welcoming you to Tel Aviv in May, we regret that, due to the challenging and uncertain circumstances in our region, the venue for ESPID 2024 has been relocated to Copenhagen, Denmark. The scientific and social programmes will remain unaffected. ESPID is the major global conference dedicated to paediatric infectious diseases, that brings together professionals…

With great enthusiasm, we announce the forthcoming "International Conference on Cardiology & Cardiovascular Research", scheduled to take place during May 20-21, 2024, in the vibrant city of Singapore. This HYBRID EVENT allows you to participate as In person at Singapore or Virtually from your home or workplace. The overarching theme of the global symposium is "Unveiling Cardiovascular Innovations for Heart Health Enhancement" Its primary objective is to expedite scientific breakthroughs and significant advancements in the realm of cardiology research and its associated domains. We extend a warm invitation to esteemed researchers, cardiologists, cardiac and cardio-thoracic surgeons, healthcare practitioners, medical school…

With great enthusiasm, we announce the forthcoming "International Conference on Cardiology & Cardiovascular Research", scheduled to take place during May 20-21, 2024, in the vibrant city of Singapore. This HYBRID EVENT allows you to participate as In person at Singapore or Virtually from your home or workplace.

While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus. As we enter a new era for cytokine therapies, armed with more cutting-edge technologies than ever before and enhanced translational understandings, the field is re-energizing the cytokine space to bring more life-changing drugs to patients. Curating learnings from previous experiences, the 5th Cytokine-Based Drug Development Summit returns as the only industry dedicated cytokine meeting with a disease agnostic approach. The…

China Consumer Health Digital Innovation Summit 2024 Date: May 21-22, 2024 Place: Shanghai, China Organizer: ECV International Tickets: Offline (On-site) &Online (Live Broadcast). Official website: https://www.ecv-events.com/ads/ConsumerHealth/index.php?cci=17 Background With the continuous promotion of the Healthy China 2030 Initiative, the consumer health market is growing stronger, reflecting the advance of health consumption awareness and the enhancement of self-health management awareness. In the post-COVID-19 era, the consumer health market has shown remarkable resilience and vitality. This summit will bring together medical and health experts, business leaders, retail pharmacy experts, and industry peers to discuss the core topics of consumer health industry, forecast the diversified needs of consumer…

Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS. Capitalizing on rapid pipeline progress and emerging industry investment, the 3rd Annual ALS Drug Development Summit returns to Boston, providing a comprehensive breakdown of the latest motor neuron models, biomarker strategies, approval insights, and novel approaches to target the likes of TDP-43, STMN2, and PIKfyve. Engage in forward-thinking discussions and gain fresh perspectives…

The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates. It has never been a more exciting time to bet on 3D tissue models as the future of drug development, as more and more complex in vitro models undergo validation. However, the big question of "when can we have the confidence in standalone 3D models, and how to do it at scale?" persists. Making its timely return to Boston…